Related Experiment Video
Updated: Nov 29, 2025

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
Interindividual Differences in Human Intestinal Microbial Conversion of (-)-Epicatechin to Bioactive Phenolic
Chen Liu1, Jacques Vervoort2, Karsten Beekmann1
1Division of Toxicology, Wageningen University and Research, Wageningen 6708 WE, The Netherlands.
Human gut microbes metabolize (-)-epicatechin (EC) differently between individuals. These differences in EC conversion and resulting metabolite patterns may influence the health effects of EC-rich foods.
Area of Science:
- Microbiology
- Metabolomics
- Human Gut Microbiome
Background:
- (-)-Epicatechin (EC) is a flavanol found in various foods and beverages.
- Interindividual variability in the human gut microbiome can influence the metabolism of dietary compounds.
- Understanding EC metabolism is crucial for assessing its potential health benefits.
Purpose of the Study:
- To quantify interindividual differences in the human intestinal microbial metabolism of (-)-epicatechin (EC).
- To identify key intermediate microbial metabolites of EC.
- To explore correlations between gut microbiota composition and EC metabolite formation.
Main Methods:
- In vitro anaerobic incubations of EC with fecal inocula from 24 healthy donors.
- Analysis of EC-derived metabolites using liquid chromatography triple quadrupole mass spectrometry (LC-TQ-MS) and liquid chromatography time-of-flight mass spectrometry (LC-TOF-MS).
- Quantitative microbiota characterization via 16S rRNA gene sequencing.
Main Results:
- Identified 1-(3',4'-dihydroxyphenyl)-3-(2″,4″,6″-dihydroxyphenyl)-2-propanol (3,4-diHPP-2-ol) and 5-(3',4'-dihydroxyphenyl)-γ-valerolactone (3,4-diHPV) as key intermediate EC metabolites.
- Demonstrated substantial interindividual differences in the rate of EC conversion and time-dependent metabolite profiles.
- Revealed significant variations in gut microbiota composition among individuals and established correlations between specific microbial phylotypes and metabolite production.
Conclusions:
- Interindividual differences in intestinal microbial metabolism of EC are significant.
- Gut microbiota composition plays a key role in shaping EC metabolite patterns.
- Variations in EC metabolism may contribute to differing health effects of EC-containing foods and drinks.
More Related Videos
13:35Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Bioavailability: Influencing Factors
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Factors Influencing Bioavailability: First-Pass Elimination
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry